中文
| Catalogue |
| Recommend Products |
Company News
- Lonza’s Rapid PyroCell® Monocyte Activation Test Systems Make Rabbit-Free Pyrogen Tes... 10/27/2023
- Lonza Upgrades MODA-ES® Module for Enhanced Electronic Batch Record Execution 9/8/2023
- Lonza Launches Nebula® Absorbance Reader for Streamlined Endotoxin and Pyrogen Testin... 8/10/2023
- Lonza Launches Nebula® Absorbance Reader for Streamlined Endotoxin and Pyrogen T... 8/8/2023
- Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Ther... 8/2/2023
- Lonza Launches TheraPRO® CHO Media System to Improve Productivity and Quality in Ther... 7/18/2023
- Lonza Launches TheraPEAK® T-VIVO® Cell Culture Medium to Accelerate Cell Therapy... 5/17/2023
- Fraunhofer IZI Selects Lonza’s MODA-ES® Solution to Digitalize Manufacturing Operatio... 12/7/2022
- Lonza and NNIT to Host Free Webinar on MES for the Future – Achieving Pharma 4.0 through A... 1/12/2022
- New Lonza Webinar – “An Automated Integrated QC Laboratory – MODA-EM® Software &... 9/13/2021
- Lonza and CN Bio Announce Distribution Agreement Providing Prevalidated Hepatocytes 7/20/2021
- Lonza Launches Next Generation 4D-Nucleofector Cell Transfection Platform 5/19/2021
- Expansion of Lonza’s Automated Robotic Solution for Endotoxin Testing Automates Sustainabl... 4/13/2021
- Lonza Celebrates 20th Anniversary of Nucleofector™ Cell Transfection Platform 4/8/2021
- Lonza Announces High-Quality Cryopreserved Leukopaks for More Flexibility in Immunology an... 1/29/2021
- Lonza’s MODA-EM™ Paperless Solution to be Implemented at the UK’s New Vaccines Manuf... 12/15/2020
- Lonza’s MODA-EM™ Paperless Solution to be Implemented at the UK’s New Vaccines Manuf... 12/8/2020
- Lonza Announces Broad Selection of High-Resolution HLA-typed Primary Cell Lots to Support ... 11/11/2020
- New Webinar – "Digitalizing Cell and Gene Therapies Manufacturing – a Lonza Case Study" 11/5/2020
- Lonza Launches the PyroCell Monocyte Activation Test System 10/9/2020